Possibility of a new synthetics from lamellarins: anti-leukemic and integrase-inhibitory effects against HTLV-1-related leukemia cells.
Possibility of a new synthetics from lamellarins: anti-leukemic and integrase-inhibitory effects against HTLV-1-related leukemia cells.
批准号:
23590641
负责人:
HASEGAWA Hiroo
金额:
$2.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
片螺素是一类从海洋无脊椎动物中分离得到的六环吡咯生物碱,具有良好的抗肿瘤活性。还报道了片螺素α 20-硫酸盐抑制HIV-1整合酶。在本研究中,我们研究了抗肿瘤活性对HTLV-1相关的白血病细胞系和活性的整合酶抑制HTLV-1通过使用新合成的片螺素。我们重点研究了一种新的片螺素合成物5号,它对HTLV-1相关的白血病细胞系和ATL细胞显示出有效的抗肿瘤活性,但对健康供体的PBMC没有伤害。基因芯片分析表明,5号制剂上调了独特的烟草中毒相关基因。我们仍在继续研究凋亡途径的机制以及由一种新的片螺素合成物引起的整合酶抑制作用。
英文摘要
Lamellarins, a family of hexacyclic pyrrole alkaloids originally isolated from marine invertebrates, has promising anti-tumor activity. It is also reported that lamellarin alpha 20-sulfate inhibits HIV-1 integrase. In the present study, we investigated anti-tumor activity against HTLV-1 related leukemia cell lines and activity of integrase inhibition of HTLV-1 by using new synthesis of lamellarins. We focused on an agent No.5, a new synthetics from lamellarins, that showed potent anti-tumor activity against HTLV-1 related leukemia cell lines and ATL cells but no harm to PBMCs from healthy donors. Microarray analysis indicated that unique apoptosis-related genes were up-regulated by the No.5 agent. We still continue investigating the mechanisms of apoptotic pathways as well as function of integrase inhibition caused by a new synthetics from lamellarins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
HTLV-1感染細胞の早期腫瘍バイオマーカーとしてのCD26抗原
CD26 抗原作为 HTLV-1 感染细胞的早期肿瘤生物标志物
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[長谷川寛雄, 塚崎邦弘, 宮崎康司, 上平憲]
通讯作者:
上平憲
DOI:
10.1186/1743-422x-9-40
发表时间:
2012-02-15
期刊:
Virology journal
影响因子:
4.8
作者:
[Kamihira S, Usui T, Ichikawa T, Uno N, Morinaga Y, Mori S, Nagai K, Sasaki D, Hasegawa H, Yanagihara K, Honda T, Yamada Y, Iwanaga M, Kanematu T, Nakao K]
通讯作者:
Nakao K
DOI:
10.3324/haematol.2010.028605
发表时间:
2011-05-01
期刊:
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
影响因子:
--
作者:
[Sasaki, Daisuke, Imaizumi, Yoshitaka, Yamada, Yasuaki]
通讯作者:
Yamada, Yasuaki
成人T 細胞白血病リンパ腫に対するHeat shock protein 90 阻害薬NVP-AUY922 の抗腫瘍効果
热休克蛋白90抑制剂NVP-AUY922对成人T细胞白血病淋巴瘤的抗肿瘤作用
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[谷口広明, 長谷川寛雄, 今泉芳孝, 塚崎邦弘, 森直樹, 宮崎泰司]
通讯作者:
宮崎泰司
DOI:
10.1038/bcj.2013.30
发表时间:
2013-08-16
期刊:
BLOOD CANCER JOURNAL
影响因子:
12.8
作者:
[Ikebe, E., Kawaguchi, A., Tezuka, K., Taguchi, S., Hirose, S., Matsumoto, T., Mitsui, T., Senba, K., Nishizono, A., Hori, M., Hasegawa, H., Yamada, Y., Ueno, T., Tanaka, Y., Sawa, H., Hall, W., Minami, Y., Jeang, K. T., Ogata, M., Morishita, K., Hasegawa, H., Fujisawa, J., Iha, H.]
通讯作者:
Iha, H.
共 20 条
Establishment of individualized test method for HTLV-1 carriers based on identification and analysis of ATL-onset clones
-
批准号:18H02733
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.32万
-
财政年份:2018
-
负责人:HASEGAWA Hiroo
-
依托单位:
Exploration new biomarkers based on HTLV-1 carrier clone analysis
-
批准号:15K08647
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2015
-
负责人:HASEGAWA Hiroo
-
依托单位:
Natural compounds that enhance TRAIL-induced apoptosis : a novel molecular targeted cancer therapy
-
批准号:18590510
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:HASEGAWA Hiroo
-
依托单位:
海外基金